A genome-wide study of lipid response to fenofibrate in Caucasians: a combined analysis of the GOLDN and ACCORD studies
Year: 2020
Type: article
Abstract: Fibrates are commonly prescribed for hypertriglyceridemia but also lower low-density lipoprotein cholesterol (LDL-C) and raise high-density lipoprotein cholesterol (HDL-C). Large inter-individual variation in lipid response suggests that some persons may benefit more than others and genetic studies could help identify those persons.
DOI: 10.17615/r998-ha33
Authors: Borecki, Ingrid B., Guo, Xiuqing, Marvel, Skylar, Hidalgo, Bertha, Claas, Steven A., Srinivasasainagendra, Vinodh, Aslibekyan, Stella, Motsinger-Reif, Alison, Chen, Ida Y.D., Ordovas, Jose M., Straka, Robert J., Buse, John B., Irvin, Marguerite R., Rotter, Jerome I., Arnett, Donna K., Wagner, Michael J., Zhi, Degui, Rotroff, Daniel M.
Institution: University of North Carolina at Chapel Hill
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4298298372
